Immix Biopharma (IMMX) Payables (2020 - 2026)
Quarterly results put Payables at $193715.0 for Q1 2026, up 52.09% from a year ago — trailing twelve months through Mar 2026 was $193715.0 (up 52.09% YoY), and the annual figure for FY2025 was $5.4 million, up 4100.71%.
Immix Biopharma has reported Payables over the past 7 years, most recently at $193715.0 for Q1 2026.
- Payables reached $193715.0 in Q1 2026 per IMMX's latest filing, down from $5.4 million in the prior quarter.
- Across five years, Payables topped out at $6.6 million in Q2 2025 and bottomed at $122594.0 in Q1 2024.
- Median Payables over the past 5 years was $1.3 million (2022), compared with a mean of $2.2 million.
- Peak annual rise in Payables hit 4100.71% in 2025, while the deepest fall reached 97.37% in 2025.
- Over 5 years, Payables stood at $1.3 million in 2022, then soared by 192.3% to $3.7 million in 2023, then plummeted by 96.52% to $129567.0 in 2024, then skyrocketed by 4100.71% to $5.4 million in 2025, then crashed by 96.44% to $193715.0 in 2026.
- Business Quant data shows Payables for IMMX at $193715.0 in Q1 2026, $5.4 million in Q4 2025, and $170896.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 300,549.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 8.69 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 1.03 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Immix Biopharma | 476.17 Mn | 476.17 Mn | - | 193,715.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 193,715.00 |
| Dec 31, 2025 | 5.44 Mn |
| Sep 30, 2025 | 170,896.00 |
| Jun 30, 2025 | 6.61 Mn |
| Mar 31, 2025 | 127,367.00 |
| Dec 31, 2024 | 129,567.00 |
| Sep 30, 2024 | 6.50 Mn |
| Jun 30, 2024 | 3.85 Mn |
| Mar 31, 2024 | 122,594.00 |
| Dec 31, 2023 | 3.72 Mn |
| Sep 30, 2023 | 2.83 Mn |
| Jun 30, 2023 | 2.40 Mn |
| Mar 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | 1.27 Mn |
| Sep 30, 2022 | 646,457.00 |
| Jun 30, 2022 | 977,209.00 |
| Mar 31, 2022 | 355,679.00 |
| Dec 31, 2021 | 192,940.00 |
| Dec 31, 2020 | 302,344.00 |